After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
CLDX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Celldex Therapeutics Inc is $1.76B. A total of 1.0 million shares were traded on the day, compared to an average of 1.19M shares.
In the most recent transaction, Marucci Anthony S bought 11,500 shares of CLDX for 26.82 per share on Nov 11 ’24. After the transaction, the PRESIDENT & CEO now owns 40,284 company shares. In a previous transaction on Jun 14 ’24, Martin Samuel Bates sold 17,172 shares at 35.42 per share. CLDX shares that SVP AND CFO owns now total 28,125.
Among the insiders who sold shares, Crowley Elizabeth disposed of 30,000 shares on Jun 14 ’24 at a per-share price of $34.87. This resulted in the SR. VP & CPDO holding 9,074 shares of CLDX after the transaction. In another insider transaction, Crowley Elizabeth sold 15,000 shares at $35.06 per share on Jun 07 ’24. Company shares held by the SR. VP & CPDO now total 9,074.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CLDX has a high of $53.18 and a low of $22.93.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CLDX’s latest balance sheet shows that the firm has $408.25M in Cash & Short Term Investments as of fiscal 2021. There were $3.04M in debt and $16.53M in liabilities at the time. Its Book Value Per Share was $11.85, while its Total Shareholder’s Equity was $419.48M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CLDX is Buy with a score of 4.67.
